The FDA said "the sterility of any injectable drugs ... produced by NECC (is) of significant concern, and out of an abundance of caution, patients who received these products should be alerted to the potential risk of infection." Woman sues over outbreak Massachusetts Gov. Deval Patrick also accused the NECC last week of misleading regulators and operating outside its license by shipping large batches of drugs nationwide. FDA urges patients to be 'vigilant' The heart transplant patient received the cardioplegic solution in August, and the patient who received the triamcinolone injection was treated on September 19 -- both before NECC recalled its products, according to an official at the federal Centers for Disease Control, who declined to be named because of the sensitivity of the subject. Federal officials say that more issues have been reported with drugs from the New England Compounding Center, or NECC, which has been linked to a deadly multistate outbreak of fungal meningitis. As part of the ongoing investigation into the center, a patient with possible meningitis has been identified who received an injection of another NECC product, triamcinolone acetonide, the Food and Drug Administration said Monday.